Abstract PS1-12-23: Pi3k/akt/mtor inhibitors in hr+/her2- breast cancer: bridging the gap between evidence and community practice in toxicity management
Year: 2026
Type: conference-abstract
Source: Clinical Cancer Research
Authors: K. Jones, T. Ackbarali, K. Jhaveri, T. Traina
Institution: Memorial Sloan Kettering Cancer Center
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7129239902
Cites:
Cited by:
Related to: